ArticlePloS one2021
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.
Lale Ozcan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticlePloS one2021
Lale Ozcan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.